[1]Tierney JF, Clarke M, Stewart LA.Is there bias in the publication of individual patient data meta-analyses[J]. Int J Technol Assess Health Care, 2000, 16(2):657-667.
[2]Advanced Ovarian Cancer Trialists Group.Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials[J]. BMJ, 1991, 303(6807):884-893.
[3]Stewart LA, Parmar MK.Meta-analysis of the literature or of individual patient data: is there a difference[J]. Lancet, 1993, 341(8842):418-422.
[4]Stewart LA, Clarke MJ. Practical methodology of meta-analyses (overviews) using updated individual patient data[J]. Stat Med, 1995, 14(19):2057-2079.
[5]Clarke MJ, Stewart LA. Meta-analyses using individual patient data[J]. J Eval Clin Pract, 1997, 3(3):207-212.
[6]Clarke M, Godwin J. Systematic reviews using individual patient data: a map for the minefields[J]. Ann Oncol, 1998, 9(8):827-833.
[7]Olkin I, Sampson A. Comparison of meta-analysis versus analysis of variance of individual patient data[J]. Biometrics, 1998, 54(1):317-322.
[8]Mathew T, Nordstr?m K.On the equivalence of meta-analysis using literature and using individual patient data[J]. Biometrics, 1999, 55(4):1221-1223.
[9]Ioannidis JP, Contopoulos-Ioannidis DG, Lau J.Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data[J]. J Clin Epidemiol, 1999, 52(4):281-291.
[10]Tierney JF, Clarke M, Stewart LA.Is there bias in the publication of individual patient data meta-analyses[J]. Int J Technol Assess Health Care, 2000, 16(2):657-667.
[11]Higgins JP, Whitehead A, Turner RM, et al. Meta-analysis of continuous outcome data from individual patient[J]. Stat Med, 2001, 20(15):2219-2241.
[12]Whitehead A, Omar RZ, Higgins JP, et al.Meta-analysis of ordinal outcomes using individual patient data[J]. Stat Med, 2001, 20(15):2243-2260.
[13]Burdett S, Stewart LA. A comparison of the results of checked versus unchecked individual patient data meta-analyses[J]. Int J Technol Assess Health Care, 2002, 18(3):619-624.
[14]Khan KS, Bachmann LM, ter Riet G.Systematic reviews with individual patient data meta-analysis to evaluate diagnostic tests[J]. Eur J Obstet Gynecol Reprod Biol, 2003, 108(2):121-125.
[15]Smith CT, Williamson PR, Marson AG.Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes[J]. Stat Med, 2005, 24(9):1307-1319.
[16]Koopman L, van der Heijden GJ, Glasziou PP, et al. A systematic review of analytical methods used to study subgroups in (individual patient data) meta-analyses[J]. J Clin Epidemiol, 2007, 60(10):1002-1009.
[17]Koopman L, van der Heijden GJ, Grobbee DE, et al.Comparison of methods of handling missing data in individual patient data meta-analyses: an empirical example on antibiotics in children with acute otitis media[J]. Am J Epidemiol, 2008, 167(5):540-545.
[18]Boccia S, De Feo E, Gallì P, etal. A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research[J]. Eur J Epidemiol, 2010, 25(11):765-775.
[19]Mathew T, Nordstrm K.Comparison of one-step and two-step meta-analysis models using individual patient data[J]. Biom J, 2010, 52(2):271-287.
[20]Abo-Zaid G, Sauerbrei W, Riley RD.Individual participant data meta-analysis of prognostic factor studies: state of the art [J]. BMC Med Res Methodol, 2012, 12:56.
[21]Ahmed I, Sutton AJ, Riley RD. Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey[J]. BMJ, 2012, 344:d7762.
[22]Saramago P, Sutton AJ, Cooper NJ, et al. Mixed treatment comparisons using aggregate and individual participant level data[J]. Stat Med, 2012, 31(28):3516-3536.
[23]Ter Riet G, Bachmann LM, Kessels AG, et al. Individual patient data meta-analysis of diagnostic studies: opportunities and challenges[J]. Evid Based Med, 2013, 18(5):165-169.
[24]Sung YJ, Schwander K, Arnett DK, et al. An empirical comparison of meta-analysis and mega-analysis of individual participant data for identifying gene-environment interactions[J]. Genet Epidemiol, 2014, 38(4):369-378.
[25]Stewart LA, Clarke M, Rovers M, et al. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement[J]. JAMA, 2015, 313(16):1657-1665.
[26]Thom HH, Capkun G, Cerulli A, et al. Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension[J]. BMC Med Res Methodol, 2015, 15:34.
[27]Polanin JR, Williams RT.Overcoming obstacles in obtaining individual participant data for meta-analysis[J]. Res Synth Methods, 2016, 7(3):333-341.
[28]Freeman SC, Carpenter JR.Bayesian one-step IPD network meta-analysis of time-to-event data using Royston-Parmar models[J]. Res Synth Methods, 2017, 8(4):451-464.
[29]孙鑫,王莉,李幼平.使用个体病例数据进行Meta分析评价医疗干预措施的效果[J]. 中国循证医学杂志,2010,10(8):998-1003.
[30]刘鸣主编.系统评价、Meta-分析设计与实施方法[M].北京:人民卫生出版社,2011.
[31]王禹毅,李迅,刘建平. 耐多药肺结核病治疗方案与结局:9153例单个病例资料Meta分析[J]. 中国药物警戒,2013,10(3):189-192.
[32]Yan SY, He LY, Liu BY.Individual Patient Data Meta-Analysis Is Needed in Chinese Medical Research[J]. 中国结合医学杂志(英文版), 2014, 20(11):805-811.
[33]艾艳珂.单个病例数据Meta分析在中医疗效评价中应用的方法学研究[D].中国中医科学院, 2015.
[34]艾艳珂,文天才,何丽云,等.单个病例数据Meta分析在中医药疗效评价中应用的思考[J]. 环球中医药,2015,8(2):190-194.
[35]赵晔,葛龙,张珺,等.单个病例数据系统评价/Meta分析优先报告条目简介[J]. 中国药物评价,2015,32(5):262-265.
[36]葛龙,李伦,刘爱萍,等.单个病例数据网状Meta分析简介[J]. 中国药物评价,2016,33(6):457-460.
[37]田金徽,李伦主编.网状Meta分析方法与实践[M].北京:中国医药科技出版社,2017.
[38]孟详喻,田国祥,拜争刚,等.生存资料的二次研究系列之二:R软件重建time-to-event结局的单个患者数据[J]. 中国循证心血管医学杂志,2016,8(2):135-137.
[39]李一杰,朱伟平,罗世坚,等.中国270例合并肝细胞癌的多原发癌个体数据Meta分析[J]. 中华肝脏外科手术学电子杂志,2017, 6(1):40-44.<br />